SCHEMBL16645014

SCHEMBL16645014

COC(=O)[C@H](Cc1ccc(C)cn1)NC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 1/20 0.45
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
TACR1 P25103 2/20 0.40
GSTP1 P09211 1/20 0.40
GSTM2 P28161 1/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC1 Q13547 2/20 0.40
CTSS P25774 3/20 0.40
CTSK P43235 2/20 0.40
TRPA1 O75762 1/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
ACE P12821 1/20 0.38
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25578541 0.89 PPARG (0.45) PPARGPPARACTSSCTSKTRPA1
SCHEMBL11915445 0.89 PPARA (0.50) PPARGPPARACTSSCTSKCTSL
SCHEMBL11915449 0.89 PPARA (0.50) PPARGPPARACTSSCTSKCTSL
SCHEMBL4074909 0.88 CTSS (0.46) KLK5PPARATACR1GSTP1GSTM2
SCHEMBL8232460 0.88 KLK5 (0.45) KLK5PPARGPPARATACR1GSTP1
SCHEMBL6560965 0.88 CTSS (0.46) KLK5PPARATACR1GSTP1GSTM2
SCHEMBL23963236 0.87 PPARG (0.44) KLK5PPARGPPARATACR1GSTP1
SCHEMBL20821189 0.87 CTSS (0.47) KLK5TACR1GSTP1GSTM2HDAC6
SCHEMBL18082636 0.87 TRPA1 (0.52) KLK5PPARGPPARATACR1GSTP1
SCHEMBL31751268 0.87 TRPA1 (0.52) KLK5PPARGPPARATACR1GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015054658-A1 MODIFIED AMINO ACIDS COMPRISING TETRAZINE FUNCTIONAL GROUPS, METHODS OF PREPARATION, AND METHODS OF THEIR USE SUTRO BIOPHARMA, INC. (US) 2015-04-16 WO disclosed